These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10094155)

  • 1. Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro.
    Saura J; Curatolo L; Williams CE; Gatti S; Benatti L; Peeters C; Guan J; Dragunow M; Post C; Faull RL; Gluckman PD; Skinner SJ
    Neuroreport; 1999 Jan; 10(1):161-4. PubMed ID: 10094155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury.
    Sizonenko SV; Sirimanne ES; Williams CE; Gluckman PD
    Brain Res; 2001 Dec; 922(1):42-50. PubMed ID: 11730700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intracerebroventricular application of insulin-like growth factor 1 and its N-terminal tripeptide on cerebral recovery following cardiac arrest in rats.
    Knapp J; Teschendorf P; Vogel P; Bruckner T; Böttiger BW; Popp E
    Resuscitation; 2013 May; 84(5):684-9. PubMed ID: 23103885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats.
    Guan J; Waldvogel HJ; Faull RL; Gluckman PD; Williams CE
    Neuroscience; 1999 Mar; 89(3):649-59. PubMed ID: 10199602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in inflammation is associated with the protective effect of Gly-Pro-Glu and cycloprolylglycine against Aβ-induced depletion of the hippocampal somatostatinergic system.
    Aguado-Llera D; Canelles S; Fernández-Mendívil C; Frago LM; Argente J; Arilla-Ferreiro E; López MG; Barrios V
    Neuropharmacology; 2019 Jun; 151():112-126. PubMed ID: 30981749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats.
    Guan J; Krishnamurthi R; Waldvogel HJ; Faull RL; Clark R; Gluckman P
    Brain Res; 2000 Mar; 859(2):286-92. PubMed ID: 10719076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats.
    Guan J; Thomas GB; Lin H; Mathai S; Bachelor DC; George S; Gluckman PD
    Neuropharmacology; 2004 Nov; 47(6):892-903. PubMed ID: 15527823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat.
    Baker AM; Batchelor DC; Thomas GB; Wen JY; Rafiee M; Lin H; Guan J
    Neuropeptides; 2005 Apr; 39(2):81-7. PubMed ID: 15752541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity.
    Alonso De Diego SA; Gutiérrez-Rodríguez M; Pérez de Vega MJ; González-Muñiz R; Herranz R; Martín-Martínez M; Cenarruzabeitia E; Frechilla D; Del Río J; Jimeno ML; García-López MT
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3396-400. PubMed ID: 16650992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of IGF-1, truncated IGF-1 and the tripeptide Gly-Pro-Glu on acetylcholine release from parietal cortex of rat brain.
    Nilsson-Håkansson L; Civalero I; Zhang X; Carlsson-Skwirut C; Sara VR; Nordberg A
    Neuroreport; 1993 Sep; 4(9):1111-4. PubMed ID: 8219036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702.
    Ahlemeyer B; Beier H; Semkova I; Schaper C; Krieglstein J
    Brain Res; 2000 Mar; 858(1):121-8. PubMed ID: 10700604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF.
    Semkova I; Schilling M; Henrich-Noack P; Rami A; Krieglstein J
    Brain Res; 1996 Apr; 717(1-2):44-54. PubMed ID: 8738252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pretective action of peptide pro-gly-pro on electrophysiological characteristics of cultured hippocampal neurones during excitotoxic damage].
    Maslov VIu; Veselovs'kyĭ MS; Moskaliuk AO; M"iasoiedov MF; Shram SI; Fedulova SA
    Fiziol Zh (1994); 2014; 60(2):3-11. PubMed ID: 25007514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminal tripeptide of insulin-like growth factor-I protects against beta-amyloid-induced somatostatin depletion by calcium and glycogen synthase kinase 3 beta modulation.
    Burgos-Ramos E; Martos-Moreno GA; López MG; Herranz R; Aguado-Llera D; Egea J; Frechilla D; Cenarruzabeitia E; León R; Arilla-Ferreiro E; Argente J; Barrios V
    J Neurochem; 2009 Apr; 109(2):360-70. PubMed ID: 19220704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of insulin-like growth factor-binding protein ligand inhibitors in vitro and in vivo.
    Mackay KB; Loddick SA; Naeve GS; Vana AM; Verge GM; Foster AC
    J Cereb Blood Flow Metab; 2003 Oct; 23(10):1160-7. PubMed ID: 14526226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPE and GPE analogues as promising neuroprotective agents.
    Cacciatore I; Cornacchia C; Baldassarre L; Fornasari E; Mollica A; Stefanucci A; Pinnen F
    Mini Rev Med Chem; 2012 Jan; 12(1):13-23. PubMed ID: 22070686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic administration of kainic acid induces selective time dependent decrease in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in adult rat hippocampal formation.
    Kar S; Seto D; Doré S; Chabot JG; Quirion R
    Neuroscience; 1997 Oct; 80(4):1041-55. PubMed ID: 9284059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide.
    Sara VR; Carlsson-Skwirut C; Bergman T; Jörnvall H; Roberts PJ; Crawford M; Håkansson LN; Civalero I; Nordberg A
    Biochem Biophys Res Commun; 1989 Dec; 165(2):766-71. PubMed ID: 2574573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats.
    Batchelor DC; Lin H; Wen JY; Keven C; Van Zijl PL; Breier BH; Gluckman PD; Thomas GB
    Anal Biochem; 2003 Dec; 323(2):156-63. PubMed ID: 14656520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.